Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 3, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.
Related news for (DVAX)
- Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
- Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
- Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
- Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference